Find your ideal
API manufacturing partner in
high-growth markets globally
List available now!
Dofetilide Patent Expiration
Dofetilide is Used for treating cardiac arrhythmia. It was first introduced by Pfizer Pharmaceuticals Production Corp Ltd in its drug Tikosyn on Oct 1, 1999. 14 different companies have introduced drugs containing Dofetilide.
Dofetilide Patents
Given below is the list of patents protecting Dofetilide, along
with the drug name that holds that patent and the company name owning that
drug.
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Dofetilide Generic API Manufacturers
Several generic applications have been filed for Dofetilide. The first generic version for Dofetilide was by Dr Reddys Laboratories Sa and was approved on Jun 6, 2016. And the latest generic version is by Teva Pharmaceuticals Usa Inc and was approved on Apr 15, 2022.
Given below is the list of companies who have filed for
Dofetilide generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Accord Hlthcare.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.125MG
capsule
Prescription
ORAL
AB
Jun 19, 2020
0.25MG
capsule
Prescription
ORAL
AB
Jun 19, 2020
0.5MG
capsule
Prescription
ORAL
AB
Jun 19, 2020
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Dofetilide. All of these versions come by the name DOFETILDE. Given below are the
details of the strengths of this generic introduced by
Aurobindo Pharma Ltd.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.125MG
capsule
Prescription
ORAL
AB
Jan 22, 2019
0.5MG
capsule
Prescription
ORAL
AB
Jan 22, 2019
0.25MG
capsule
Prescription
ORAL
AB
Jan 22, 2019
Manufacturing Plant Locations
New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
Country
City
Firm Name
India
Medchal
Aurobindo Pharma Ltd
3. BIONPHARMA
Bionpharma Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Bionpharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.125MG
capsule
Prescription
ORAL
AB
Apr 10, 2018
0.5MG
capsule
Prescription
ORAL
AB
Apr 10, 2018
0.25MG
capsule
Prescription
ORAL
AB
Apr 10, 2018
Manufacturing Plant Locations
New
Bionpharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bionpharma as present at those locations.
Country
City
Firm Name
United States
Princeton
Bionpharma Inc.
4. DR REDDYS LABS SA
Dr Reddys Laboratories Sa has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Dr Reddys Labs Sa.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.125MG
capsule
Prescription
ORAL
AB
Jun 6, 2016
0.25MG
capsule
Prescription
ORAL
AB
Jun 6, 2016
0.5MG
capsule
Prescription
ORAL
AB
Jun 6, 2016
5. GRANULES
Granules Pharmaceuticals Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Granules.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.5MG
capsule
Prescription
ORAL
AB
Oct 14, 2021
0.25MG
capsule
Prescription
ORAL
AB
Oct 14, 2021
0.125MG
capsule
Prescription
ORAL
AB
Oct 14, 2021
Manufacturing Plant Locations
New
Granules's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Granules as present at those locations.
Country
City
Firm Name
United States
Chantilly
Granules Pharmaceuticals Inc.
Manassas
Granules Consumer Health Inc.
India
Sangareddy District
Granules India Limited
Medchal-Malkhajgiri District
Granules India Limited
Secunderabad
Granules India Limited
Parawada Mandal
Granules India Limited
Visakhapatnam
Granules India Limited
6. MSN
Msn Laboratories Private Ltd has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Msn.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.5MG
capsule
Prescription
ORAL
AB
Jan 29, 2020
0.25MG
capsule
Prescription
ORAL
AB
Jan 29, 2020
0.125MG
capsule
Prescription
ORAL
AB
Jan 29, 2020
Manufacturing Plant Locations
New
Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.
Novast Laboratories Ltd has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Novast Labs.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.125MG
capsule
Discontinued
ORAL
N/A
Dec 27, 2019
0.25MG
capsule
Discontinued
ORAL
N/A
Dec 27, 2019
0.5MG
capsule
Discontinued
ORAL
N/A
Dec 27, 2019
8. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Prinston Inc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.5MG
capsule
Discontinued
ORAL
N/A
Dec 17, 2019
0.125MG
capsule
Discontinued
ORAL
N/A
Dec 17, 2019
0.25MG
capsule
Discontinued
ORAL
N/A
Dec 17, 2019
9. RK PHARMA
Rk Pharma Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Rk Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.25MG
capsule
Discontinued
ORAL
N/A
Apr 14, 2022
0.5MG
capsule
Discontinued
ORAL
N/A
Apr 14, 2022
0.125MG
capsule
Discontinued
ORAL
N/A
Apr 14, 2022
Manufacturing Plant Locations
New
Rk Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Rk Pharma as present at those locations.
Country
City
Firm Name
United States
Pearl River
RK Pharma Inc.
10. SIGMAPHARM LABS LLC
Sigmapharm Laboratories Llc has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Sigmapharm Labs Llc.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.125MG
capsule
Prescription
ORAL
AB
Mar 26, 2018
0.25MG
capsule
Prescription
ORAL
AB
Mar 26, 2018
0.5MG
capsule
Prescription
ORAL
AB
Mar 26, 2018
11. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Strides Pharma.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.125MG
capsule
Prescription
ORAL
AB
Oct 9, 2018
0.25MG
capsule
Prescription
ORAL
AB
Oct 9, 2018
0.5MG
capsule
Prescription
ORAL
AB
Oct 9, 2018
Manufacturing Plant Locations
New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
Country
City
Firm Name
United States
Chestnut Ridge
Strides Pharma, Inc.
East Brunswick
Strides Pharma Inc.
India
Puducherry
Strides Pharma Science Limited
Bangalore
Strides Pharma Science Limited
12. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Sun Pharm.
Strength
Dosage Form
Availability
Application Pathway
TE code
Launch Date
0.5MG
capsule
Prescription
ORAL
AB
Oct 9, 2018
0.125MG
capsule
Prescription
ORAL
AB
Oct 9, 2018
0.25MG
capsule
Prescription
ORAL
AB
Oct 9, 2018
Manufacturing Plant Locations
New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
Country
City
Firm Name
United States
Billerica
Sun Pharmaceutical Industries, Inc.
Lexington
Sun Pharmaceutical Industries Inc
Princeton
SUN PHARMACEUTICAL INDUSTRIES INC
India
Malanpur, Bhind (District)
Sun Pharmaceutical Industries Limited
Baruch
Sun Pharmaceutical Industries Ltd.
Kanchipuram
Sun Pharmaceutical Industries Limited- Madhuranthagam
Dadra
Sun Pharmaceutical Industries Limited
Vadodara
Sun Pharmaceutical Industries Ltd
Bharuch
Sun Pharmaceutical Industries Ltd
Halol
Sun Pharmaceutical Industries Ltd.
Mohali
Sun Pharmaceutical Industries Limited
Vadodara
Sun Pharmaceutical Industries Limited - Karkhadi
Gurugram
Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Punjab
Sun Pharmaceutical Industries, Inc.
Ahmednagar
Sun Pharmaceutical Industries Limited
Vadodara
Sun Pharmaceutical Industries Ltd.
New Delhi
Sun Pharmaceutical Industries Limited
13. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Dofetilide. Given below are the
details of the strengths of this generic introduced by
Teva Pharms Usa.
